This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Understanding the mechanics of flow artifacts on CT or CT angiography (CTA) and how these artifacts are created is key to better disease diagnosis, according to a review published April 25 in RadioGraphics. In the review, a team led by Caroline Robb, MD, of Mallinckrodt Institute of Radiology, Washington University in St. Louis, MO, described flow artifacts and how they are different from several types of conditions.
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment, according to a study published April 25 in JHEP Reports. A group led by researchers at the University of Hong Kong in China found the approach detected 12% more disease in patients undergoing staging than CT or MRI and resulted in a change in treatment in a significant number of cases.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The U.S. Preventive Services Task Force (USPSTF) is inviting comment as it develops a draft recommendation for assessing cardiovascular disease (CVD) via coronary artery calcium (CAC) scoring or the ankle-brachial index. The task force is considering the following questions: What is the effectiveness or comparative effectiveness of enhanced cardiovascular disease risk assessment with coronary artery calcium scoring or the ankle-brachial index on cardiovascular health outcomes?
Image-based questions were significantly more challenging for the large language model to answer, despite the latest version now being capable of accepting image prompts.
Radiation therapy clinic software provider RaySearch Laboratories highlighted a net sales increase of 21% in its 2023 annual report, posting 1.02 billion Swedish krona ($93.2 million U.S.). The Stockholm, Sweden-based company also reported an operating loss/profit of 114.9 million Swedish krona ($10.5 million U.S.), an increase of 169% over 2022. Operating margin also increased to 11.2% in 2023, up from 5.1% in 2022.
Researchers outline how they used a chemical probe to light up interlocking peptides. Their technique will help scientists differentiate synthetic peptides from toxic types found in Alzheimer's disease.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Fujifilm Healthcare Americas has launched its OPIE Transducer, an on-pump intracardiac echocardiography transducer for aiding septal myectomy procedures. OPIE is a possible alternative to using transesophageal echocardiography (TEE) to view septal thickness before septal myectomy. With OPIE, a thin transducer is passed into the heart; images of the patient’s septal thickness can be seen in real-time, according to Fujifilm.
Automates repositioning during surgery Has potential to address staff shortages and work overload in operating rooms Can be moved effortlessly thanks to its fully motorized chassis and touch-sense handles Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the CIARTIC Move , a mobile C-arm with self-driving capabilities.
A groundbreaking technology offers precise, automatic measurement of peripheral blood vessels to optimize treatment strategies for those who suffer from.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Reportedly the smallest and thinnest implantable spinal cord stimulator (SCS) device, the Inceptiv closed-loop SCS modality allows access to 1.5T and 3T full-body MRI without power restrictions.
Genicular artery embolization (GAE) is an emerging, minimally invasive therapy to address the global burden of knee osteoarthritis (OA) and the unmet needs for medically refractory disease. Although total knee arthroplasty has been a standard intervention for severe cases, GAE is developing into a promising alternative, particularly for patients ineligible for or unwilling to undergo surgery.
To compare the risk of hemorrhagic complications of transthoracic needle biopsy such as pulmonary hemorrhage and hemoptysis between patients with pulmonary hypertension and patients without pulmonary hypertension.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
To conduct a systematic review to evaluate the safety and efficacy of endovascular treatment with stent grafts (SGs) for complications associated with persistent sciatic artery (PSA).
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content